The chemical class known as eIF6 Activators encompasses a range of compounds specifically designed to modulate the activity of eukaryotic translation initiation factor 6 (eIF6), a protein pivotal in the regulation of ribosomal assembly and protein synthesis in eukaryotic cells. These activators work by influencing the interaction between eIF6 and the 60S ribosomal subunit, a critical step in the formation of the functional 80S ribosome necessary for protein translation. The precise mechanisms by which these activators function can vary, but they generally target the binding affinity, stability, or conformational dynamics of eIF6, thereby facilitating its role in ribosomal assembly. This can involve either enhancing the binding efficiency of eIF6 to the 60S subunit or modulating its release, ensuring the timely and efficient formation of the 80S ribosome.
The significance of eIF6 Activators lies in their ability to modulate a fundamental cellular process – protein synthesis. By targeting eIF6, these activators can influence the rate and efficiency of protein production, which is a central aspect of cell growth, division, and overall function. The regulation of protein synthesis is a highly complex and finely tuned process, and eIF6 plays a critical role in ensuring that ribosomes are assembled correctly and at the appropriate time. eIF6 Activators, therefore, represent a focused approach to influencing this process, offering a means to alter the dynamics of ribosomal assembly. Their action is particularly notable in scenarios where the regulation of protein synthesis is of paramount importance, such as in various cellular growth and maintenance processes. The study and development of eIF6 Activators contribute significantly to the broader understanding of translational control and ribosome biogenesis, shedding light on the intricate mechanisms that govern these essential cellular activities.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Might upregulate eIF6 indirectly by altering downstream protein synthesis pathways, potentially relieving feedback inhibition on pathways that control eIF6 expression. | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $292.00 $822.00 $1540.00 | 1 | |
Could upregulate eIF6 as an AMPK activator, influencing metabolic pathways and indirectly enhancing eIF6 expression as part of a broader response to altered energy states in the cell. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As an HDAC inhibitor, could upregulate eIF6 by affecting chromatin structure and gene expression, potentially enhancing the accessibility of the eIF6 gene for transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor could potentially upregulate eIF6 by altering DNA methylation patterns, thereby enhancing gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
As a regulator of gene expression, could upregulate eIF6 expression, particularly in contexts where cell differentiation and growth are involved. | ||||||